Glenmark Life Sciences has filed its RHP and will be the fifth initial public offering (IPO) to open in July 2021. Here are some details:
Issue date: July 27 to 29
Price band: Rs 695 to Rs 720
Issue size: Rs 1,600 crore
Listing date: August 6
ALSO WATCH: Policybazaar IPO aims to raise Rs 6,500 crore likely to file DRHP in a week
Glenmark Life Sciences is a leading developer and manufacturer of select high-value Active Pharmaceutical Ingredients (APIs) in chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company develops, manufactures, and supplies high-quality APIs globally.